David LinetskyPoint-of-Care Marketing
Matt TurnerPatient Affordability
Daniel SontupeMarket Access
Matthew DurhamOmnidynamic Marketing
Amy GilesIncreasing Engagement
Paul TheisenPatient Acquisition
Frank BurrellScientific Storytelling
Joey CohenMedication Adherence
Suma Ramadas, PhDMedical Affairs
Brenda SnowAuthentic Patient Voice
Stacey GandlerBrand Nourishment
Liz KaneImpactful Strategy
Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
SAN RAMON, Calif., June 06, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a ...
- Tolerability and proof-of-mechanism for lead candidate AVB-S6-500, a novel GAS6-AXL pathway inhibitor, established ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email